Clinical Trial

User Experience With DuraTouch® in Patients With Type 1 or Type 2 Diabetes

Completed
View on ClinicalTrials.gov →
Summary
This study looks at overall impact of the use of DuraTouch® in terms of ease, convenience to use and satisfaction in participants with either type 1 or type 2 diabetes.The study will last for about 12 weeks.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-06-26; most recent amendment 2026-04-03.
Status change: Active, Not Recruiting → Completed 2026-04-03
Status change: Recruiting → Active, Not Recruiting 2025-11-26
Status change: Not Yet Recruiting → Recruiting 2025-09-16
Trial Details
NCT Number NCT07052292
Lead Sponsor Novo Nordisk A/S
Conditions Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Enrollment 128 participants
Start Date 2025-07-01
Primary Completion 2026-01-09 (estimated)
Study Completion 2026-01-09 (estimated)
Updated on ClinicalTrials.gov 2026-04-09